IBS-BEHANDLUNG MIT PROBIOTIKA

European patent · EP3329927 · In force

Register entry

Publication number
EP3329927
Application number
EP17198980
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 16, 2012
Published
Jun 6, 2018
Granted
Sep 27, 2023
Protection ends at the latest
Nov 15, 2032
Next annual fee due
Nov 30, 2026
IPC classes
A61K 35/744 (2015.01)
A61K 35/747 (2015.01)
A61P 1/00 (2006.01)
A61P 1/04 (2006.01)
A61P 1/10 (2006.01)
A61P 1/12 (2006.01)
A61K 36/8998 (2006.01)
Priority
GB 201119774 16.11.2011
GB 201121207 09.12.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Aug 7, 2024

    Change

    Published in Swissreg on 07.08.2024

  4. Feb 19, 2024

    Change

    Published in Swissreg on 19.02.2024

  5. Nov 1, 2023

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 01.11.2023

  6. Sep 27, 2023

    Granted

    Published in Swissreg on 27.09.2023

Parties

Holder

Multigerm UK Enterprises Ltd.

Sandy Farm Business Centre The Sands Farnham, Surrey GU10 1PX, GB

Agent

Kirker & Cie SA

Rue de Genève 122 CP 153, 1226 Genève-Thônex

Inventor

SMITH, Barry Edward

Furnham, Surrey GU10 1PX, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.